Dr. David Samadi and His Premiere TV Program

Most aired television shows and news programs distinctly divide the viewers into two in the long run. It is crucial therefore to feature reliable experts who deliver trustworthy information. Sunday Housecall with Dr. David Samadi is one such program that debuted live in September 2017 and airs weekly every Sunday at 12.30. It is also accessible on social media mainstreams like Facebook or YouTube as well as Dr. Samadi’s website.

Dr. David Samadi is a renowned medical expert who gained attention for his role as a news commentator on Fox News. He is known for his medical expertise and relatable character. He is well suited to host Sunday House call TV program that diabolically discusses warring major health issues. Dr. Samadi is a board certified urological oncologist who specializes in early diagnosis and treatment of proctological and urological cancer. He has an established practice and is vitally endowed with skills and knowledge on Robotic surgery that is safer and minimally invasive to patients.

The show is aimed at achieving overall wellbeing for its viewers. It is centered on vital topics that are derived from dynamic health subjects. Dr. Samadi sources for well vetted experts who offer smart discussions on the topics. They are adequately equipped to provide unique, concise and rounded perspectives pertaining raised health issues. The show incorporates viewer insights by receiving questions that are addressed on the program, and http://www.davidsamadibio.com/.

Dr. David Samadi has attained admirable academic and professional skills in urology and robotics in his career. After leaving Iran, he completed his high school education in the U.S before acquiring a full sponsorship to Stony Brook University. He graduated with a degree in Biochemistry from Stony Brook and MD from S.U.N.Y, Sony Brook School of Medicine. He has a postgraduate degree in urology and proctology from Montefiore Medical Centre and Albert Einstein College of Medicine. He has successfully attended oncology fellowship in Hemorial Sloan Kettering Cancer Center. His determination drove him to perfect his skills on robotics at Henri Mandir Hospital Creteil in France.

How Alzheimer’s changes the brain.#health #healthtips #prevention https://t.co/OxYoZ7cAk0

— Dr. David Samadi(@drdavidsamadi) November 16, 2017

David Samadi’s reputation has earned him worldwide respect and admiration. He has worked with prestigious hospitals that have intensified his skills. He is currently the head of urology department and is in charge of robotic surgeries at Lenox Hill Hospital. He is sought by patients who trust in his work and advice as they are assured of quality care. His premiered TV show is set to drive his agenda of providing enriched health information to viewers. The program has continuously proved to be beneficial as can be seen in constant growth in number of followers, and learn more about David Samadi.

Eric Lefkofsky, Dedicated Philanthropist and Entrepreneur, Turns his Eyes to Data Enabled Cancer Treatment

With the rates of cancer in the U.S. increasing to an expected 19 million diagnoses by 2024, many are wondering about the advancements in cancer treatment. In the Tech News Spy article “Tempus, Eric Lefkofsky, and the Rise of Data-Enabled Precision Medicine”, author Heidi Harris discusses Tempus’ paradigm shift in cancer treatment.

Despite the development of technology in electronic health records, the healthcare industry can seem behind in terms of modern technology. Eric Lefkofsky experienced this himself when his wife was diagnosed with cancer. During her treatment, they found there was a lack of digital technology to inform treatment plans, making it much more difficult to decide the best course of treatment.

After this experience, Eric Lefkofsky decided to make a change. He co-founded Tempus with the idea to create a platform that evaluates molecular and clinical data for each individual patient. With the advancements of genome sequencing, the company can provide in-depth information for each tumor. They also provide a library of clinical data and molecular information so physicians can see what treatment worked best with patients of similar molecular makeup and learn more about Eric.

As cancer research advances, experts have found that understanding the genomic data can provide clues on how to fight the disease more effectively. Tempus provides that pairing between genome sequencing with clinical information. By doing so, the company is able to help doctors create a data-enabled treatment plan with the hopes of creating more effective treatment plans for each individual.

By pairing the treatments with the cancer treatment, doctor’s will likely be able to determine which treatments and medicines are more likely to work. The library is continuously updated and provides real-time access to the information, allowing doctors to make immediate decisions regarding treatment and more information click here.

Eric Lefkofsky is a leading member of Chicago’s elite. He is not only on the board of the Art Institute of Chicago, the Children’s Hospital, and World Business Chicago, but he is also a Trustee of the Steppenwolf Theatre company and a dedicated philanthropist.

He also seeks to spread his knowledge through teaching. He is an Adjunct Professor at the Booth School of Business in the University of Chicago. There he teaches courses on technology based-business and entrepreneurship. He has also taught at DePaul University and Northwestern University and Eric’s lacrosse camp.